Which drug class is known to promote norepinephrine release (as part of its mechanism)?

Which drug class is known to promote norepinephrine release (as part of its mechanism)?

• A. Amphetamines, Tyramine and Ephedrine
• B. Acetazolamide, Furosemide and Hydrochlorothiazide
• C. Beta-blockers
• D. Anticholinergics

Answer: (A)

Indirect-acting sympathomimetics promote norepinephrine release from sympathetic nerve terminals. Amphetamines fit this pattern by entering the nerve terminal and displacing stored norepinephrine from vesicles, increasing cytosolic NE and driving more NE into the synapse; they can also inhibit breakdown to boost the effect. Tyramine acts similarly but is typically kept in check by monoamine oxidase; when MAO is inhibited, tyramine causes a surge of NE release, which can lead to dangerous hypertensive responses. Ephedrine serves as a mixed mechanism agent that both releases NE and directly stimulates adrenergic receptors, all of which increase NE activity in the synapse. In contrast, the other options do not promote NE release. Agents that are diuretics or carbonic anhydrase inhibitors affect renal ion transport rather than presynaptic NE release. Beta-blockers block adrenergic receptors, not NE release. Anticholinergics affect muscarinic receptors rather than promoting NE release.

Indirect-acting sympathomimetics promote norepinephrine release from sympathetic nerve terminals. Amphetamines fit this pattern by entering the nerve terminal and displacing stored norepinephrine from vesicles, increasing cytosolic NE and driving more NE into the synapse; they can also inhibit breakdown to boost the effect. Tyramine acts similarly but is typically kept in check by monoamine oxidase; when MAO is inhibited, tyramine causes a surge of NE release, which can lead to dangerous hypertensive responses. Ephedrine serves as a mixed mechanism agent that both releases NE and directly stimulates adrenergic receptors, all of which increase NE activity in the synapse.

In contrast, the other options do not promote NE release. Agents that are diuretics or carbonic anhydrase inhibitors affect renal ion transport rather than presynaptic NE release. Beta-blockers block adrenergic receptors, not NE release. Anticholinergics affect muscarinic receptors rather than promoting NE release.